Skip to main content

Table 1 Patients, tumor and treatment characteristics

From: Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma

Variable

p16+/HPV+

N (%)

p16−/HPV-

N (%)

p-value

N = 546 (89.4%)

N = 65 (10.6%)

Age

p = 0.84

  < 50

86 (15.8)

11 (16.9)

 50- < 60

231 (42.3)

25 (38.5)

  ≥ 60

229 (41.9)

29 (44.6)

Sex

p < 0.0001*

 Male

473 (86.6)

44 (67.7)

 Female

73 (13.4)

21 (32.3)

Race

p = 0.08

 White

505 (92.5)

56 (86.2)

 Non-white

41 (7.5)

9 (13.8)

Cancer subsite of origin

p = 0.8

 Base of tongue

250 (45.8)

27 (41.5)

 Tonsil

252 (46.2)

26 (40)

 Other

44 (8)

12 (18.5)

CCI

p = 0.7

 0 (No comorbidity)

436 (80)

49 (75)

  ≥ 1 (At least one comorbidity)

110 (20)

16 (25)

T-category

p = 0.09

 T1

168 (30.8)

17 (26.2)

 T2

211 (38.6)

18 (27.6)

 T3

98 (17.9)

15 (23.1)

 T4

69 (12.7)

15 (23.1)

N-category

p < 0.0001*

 N0

39 (7.1)

8 (12.3)

 N1

373 (68.3)

10 (15.4)

 N2

121 (22.2)

45 (69.2)

 N3

13 (2.4)

2 (3.1)

AJCC (8th edition)

p < 0.0001*

 I

316 (57.9)

1 (1.5)

 II

149 (27.3)

4 (6.2)

 III

81 (14.8)

13 (20.0)

 IV

0

47 (72.3)

Smoking status at diagnosis

< 0.0001

 Current smoker

101 (18.5)

25 (38.46)

 Former smoker

208 (38.1)

28 (43.08)

 Never smoker

249 (40.75)

12 (18.46)

Tobacco exposure (PY)

p < 0.0001*

 0

277 (50.7)

13 (20)

  > 0–10

87 (15.9)

6 (9.2)

  > 10–20

50 (9.2)

8 (12.3)

  > 20–30

46 (8.4)

11 (17)

  > 30

86 (15.8)

27 (41.5)

Tobacco exposure per AJCC (8th edition) stage

p < 0.0001

 I/pack-years < 30

263 (48.2)

1 (1.5)

 I/pack-years ≥30

53 (9.7)

0

 II/pack-years < 30

113 (20.7)

1 (1.5)

 II/pack-years ≥30

36 (6.6)

3 (4.6)

 III/pack-years < 30

59 (10.8)

4 (6.2)

 III/pack-years ≥30

22 (4)

9 (13.8)

 IV/pack-years < 30

0

27 (41.6)

 IV/pack-years ≥30

0

20 (30.8)

Chemotherapy (Cth) sequence

p = 0.94

 No Cth

99 (18.1)

12 (18.5)

 Induction Cth (IC) only

82 (15.0)

8 (12.2)

 Concurrent Cth (CC) only

210 (38.5)

25 (38.5)

 IC + CC

155 (28.4)

20 (30.8)

  1. Abbreviations: EBRT external beam radiation therapy, IC induction chemotherapy, CEBRT concurrent chemotherapy + EBRT. * indicates p < 0.05 when comparing the HPV+ and HPV- groups